Podcast 1 Nov 2024The immunometabolism landscape To talk about immunometabolism, our guest on the podcast this week is CEO of Sitryx Therapeutics, Iain Kilty. November 1, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 25 Oct 2024Biotech beyond earth: The future of medicine in space LinkGevity was selected for a NASA program for its potential to minimize the health and performance risks in human spaceflight. Find out more! October 25, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 18 Oct 2024The future of gene therapy This week, we have a conversation with Michael Parini, CEO of Spur Therapeutics, about the future of gene therapy. October 18, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 11 Oct 2024Bispecific ADCs: the next generation of cancer treatments To talk about bispecific ADCs, and biotechs in Czechia, our conversation this week is with Radek Špíšek, CEO of SOTIO. October 11, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 4 Oct 2024Targeting telomerase to disrupt cancer Listen to our conversation with Vlad Vitoc, CEO of MAIA, on the pioneering approach of telomere targeting October 4, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 27 Sep 2024Harnessing the body’s natural targeted protein degradation system to treat diseases Listen to our conversation with Andrew Hirsch, CEO at C4 Therapeutics, a leader in the targeted protein degradation field. September 27, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 20 Sep 2024Estonia’s biobank: Is this the first large-scale personalized medicine initiative? Estonia is working on becoming the first country to implement personalized health at scale through the Estonian National Biobank. September 20, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 13 Sep 2024Targeting inflammation: A revolution in disease treatment NLRP3 inflammasome-induced inflammation is at the root of nearly all disease pathologies. Listen to our conversation with Halia Therapeutics about it. September 13, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 12 Sep 2024New treatments being developed for schizophrenia Explore the latest strides in schizophrenia treatment development as 2024 heralds a pivotal year, with promising collaborations and trials. September 12, 2024 Share WhatsApp Twitter Linkedin Email
Podcast 6 Sep 2024The power of tumor infiltrating lymphocytes to fight melanoma Listen to our conversation with Brian Gastman, EVP of medical affairs at Iovance Biotherapeutics, about TILs and the company’s pipeline. September 6, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 30 Aug 2024The future of combination vaccines To look at combination vaccines, listen to our conversation with Cesar Sanz Rodriguez, vice president, Europe & Switzerland, medical affairs, at Moderna. August 30, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 23 Aug 2024New German biotech spins out to develop radiotherapeutics While it is currently owned by the Eckert & Ziegler Group, Pentixapharm will soon be spun off as a separate company. Listen to our conversation with Andreas Eckert, founder of the company August 23, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More